Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
Status unconfirmed
Conditions studied: Diabetic Macular Edema
In brief
This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME) in diabetic patients that undergo a DME screening exam. The screening exam will consist of medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus photography
Key facts
- Study ID
- NCT01934920
- Run by
- Elman Retina Group
- People needed
- 500
- Starts
- 2016-08-01
- Expected to finish
- 2019-05-01
- Last updated by the study team
- 2019-02-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Ability to provide written informed consent and comply with study assessments for the full duration of the study
- Age > 18 years
- Patient related considerations
- Patients with diabetes mellitus
- Disease related considerations
- Diabetes mellitus
You may not qualify if…
- Prior admission screening within twelve months.
- Inability to sit for evaluation
Where it is running
- Aaron Goldberg, Primary Care — Baltimore, Maryland, United States (enrolling)
- MedStar Hospital — Baltimore, Maryland, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.